FABP1 and metabolic dysfunction-associated steatotic liver disease: These findings align with previous research, which has highlighted the potential of L-FABP as a diagnostic and prognostic marker in MASLD due to its involvement in lipid metabolism and its elevated expression in various liver conditions [20,54,55].